Toronto - Delayed Quote CAD
Aptose Biosciences Inc. (APS.TO)
2.3800
+0.0100
+(0.42%)
At close: June 13 at 3:59:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -2.74 | -1.95 | -9.2 | -5.65 |
| Low Estimate | -2.74 | -1.95 | -9.2 | -5.65 |
| High Estimate | -2.74 | -1.95 | -9.2 | -5.65 |
| Year Ago EPS | -12.9 | -11.1 | -36.38 | -9.2 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | -- |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -17.4 | -19.2 | -6.78 | -2.67 |
| EPS Actual | -12.9 | -11.1 | -34.9 | -2.61 |
| Difference | 4.5 | 8.1 | -28.13 | 0.06 |
| Surprise % | 25.86% | 42.19% | -415.13% | 2.25% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -2.74 | -1.95 | -9.2 | -5.65 |
| 7 Days Ago | -2.74 | -1.95 | -9.2 | -5.65 |
| 30 Days Ago | -2.74 | -1.95 | -9.2 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| APS.TO | 78.76% | 82.43% | 74.71% | 38.59% |
| S&P 500 | 13.13% | 2.43% | 7.54% | 14.06% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/28/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/12/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/10/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/10/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/3/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/20/2024 |
Related Tickers
FRX.TO Fennec Pharmaceuticals Inc.
10.76
-5.11%
PMN ProMIS Neurosciences, Inc.
0.5195
-0.10%
RFM.F Sensorion SA
0.3600
+4.05%
HBP.TO Helix BioPharma Corp.
0.9300
0.00%
ACTU Actuate Therapeutics, Inc. Common stock
8.65
+0.46%
TELI.CN Telescope Innovations Corp.
0.4800
0.00%
ANL Adlai Nortye Ltd.
1.6290
+1.81%
MDNA.TO Medicenna Therapeutics Corp.
0.9000
-2.17%
COYA Coya Therapeutics, Inc.
5.63
+4.84%
BRNS Barinthus Biotherapeutics plc
0.9033
-3.27%